Director, Inventory / Cost Accounting
Dyne Therapeutics
Director, Inventory / Cost Accounting
Dyne Therapeutics
Develops muscle-disease therapies using FORCE platform
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Director, Inventory / Cost Accounting leads Dyne’s inventory and cost accounting strategy and established the financial infrastructure required to support commercial launch and continued portfolio growth. This role owns the development, implementation and governance of cost accounting processes, inventory valuation, and related controls across clinical and commercial products manufactured through third-party CMOs and CDMOs.. The Director serves as the company’s subject matter expert for inventory and cost accounting, providing strategic guidance on product costs, capitalization, reserves, gross margin, and complex accounting judgments. This highly visible role influences business decisions by translating manufacturing and supply chain activity into clear financial insights and recommendations for senior leadership.
The Director partners closely with Supply Chain, Technical Operations, Commercial Operations, FP&A, external manufacturing partners, and auditors to ensure accurate, scalable, and audit-ready processes. This role sets priorities, directs cross-functional initiatives, and develops the capabilities and resources needed to support Dyne’s transition from clinical development to a multi-product commercial organization.
This is a full-time position based in Waltham, MA without the possibility of being remote.
Primary Responsibilities Include:
Cost Accounting & Costing Methodology
Inventory Accounting
CMO/CDMO Cost Management
Financial Reporting & Controls
Cross-Functional Partnership & Process Building
Education and Skills Requirements:
#LI-Onsite
The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
MA Pay Range 200000 - 230000 USD
Develops muscle-disease therapies using FORCE platform
Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.
Explore more opportunities at Dyne Therapeutics